Logo via Cigna

Cigna Helps Accelerate Research for a COVID-19 Treatment by Donating Medications

Originally published on Cigna.com 

Cigna Helps Accelerate Research for a COVID-19 Treatment by Donating Medications to Washington University School of Medicine’s Clinical Trial

  • Research to evaluate whether combination treatments of antimalarial drugs and antibiotics decrease respiratory symptoms for COVID-19 patients

To accelerate research for a COVID-19 treatment, Cigna is providing medications to Washington University School of Medicine in St. Louis to initiate a clinical trial that will evaluate antimalarial and antibiotic treatments for COVID-19. The researchers plan to enroll 500 patients, over the course of the study, hospitalized with the novel coronavirus at Barnes – Jewish Hospital in St. Louis, MO.

“Finding a proven treatment for COVID-19 is the most pressing global public health priority,” said Dr. Steve Miller, MD, Chief Clinical Officer, Cigna. “Through our close collaboration with Washington University, we can help fast-track this effort.”

The Food and Drug Administration (FDA) recently granted emergency approval for hospitals to use antimalarial drugs chloroquine and hydroxychloroquine for treatment of COVID-19 in hospitalized patients. The Washington University School of Medicine has implemented a pilot trial investigating the use of these medications in combination with the antibiotic azithromycin to identify the most effective combinations and dosages that will decrease the severity and duration of respiratory symptoms and speed recovery for COVID-19 patients.

Chloroquine and hydroxychloroquine are oral prescription drugs approved to treat malaria and other diseases. Anecdotal reports and in vitro trials suggest these drugs might be useful in treating coronaviruses, including SARS-CoV-2, the virus that causes COVID-19, but definitive evidence is needed.

“There have been only a few small studies that have evaluated chloroquine and hydroxychloroquine in patients with COVID-19, and the results are unclear,” said Infectious Disease Specialist, Rachel M. Presti, MD, PhD, an associate professor of medicine at Washington University School of Medicine, who is co-leading the trial. “Our goal is to determine if any of these medications, alone or in combination, decrease the severity or duration of respiratory symptoms associated with COVID-19.”

Preliminary data could be available as early as six weeks.

About Cigna
Cigna Corporation is a global health service company dedicated to improving the health, well-being and peace of mind of those we serve. Cigna delivers choice, predictability, affordability and access to quality care through integrated capabilities and connected, personalized solutions that advance whole person health. All products and services are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Cigna Health and Life Insurance Company, Cigna Life Insurance Company of New York, Connecticut General Life Insurance Company, Express Scripts companies or their affiliates, and Life Insurance Company of North America.

Such products and services include an integrated suite of health services, such as medical, dental, behavioral health, pharmacy, vision, supplemental benefits, and other related products including group life, accident and disability insurance. Cigna maintains sales capability in over 30 countries and jurisdictions, and has more than 170 million customer relationships throughout the world. To learn more about Cigna®, including links to follow us on Facebook or Twitter, visit www.cigna.com.

 

Latest News

KPMG: Driving Inclusive Virtual Collaboration

Originally published on info.KPMG.us by Michele Meyer-Shipp As social distancing and virtual work have become our new normal, here are five suggestions to help ensure everyone on your team feels included and valued: Communicate often and in different ways. One of the challenges of working remotely is feeling isolated, especially if you’re…

Hershey Stockholders Elect Victor L. Crawford To Company Board

Originally published on thehersheycompany.com. HERSHEY, Pa., May 18, 2020 (GLOBE NEWSWIRE) — The Hershey Company (NYSE: HSY) today announced the election of Victor L. Crawford to its board of directors. Crawford is the newest Hershey board member and was elected at the company’s recent Annual Stockholder’s Meeting. Victor L. Crawford Crawford brings deep executive and leadership experience to…

Nielsen Publishes Asian American Consumer Report for Asian American and Pacific Islander Heritage Month

Originally published on nielsen.com. REPRESENTATION MATTERS Asian Americans are a driving force in the U.S., both as cultural influencers and powerful consumers. Your representation within the products and media you love begins with data. At Nielsen, we provide a cultural narrative for diverse communities through our research. Below you will…

BASF Embraces Personalization in Cosmetics

Originally posted on BASF.com  New concept answers worldwide trend for personalized care products BASF designs customizable Face and Hair Care formulations Mixing and matching of boosters allows for countless combinations More and more people consider beauty and care routines as a key to individualization and diversity. BASF is meeting the…

Dow Collaborates to Manufacture and Donate Much-Needed Respirators Through WIN Health Labs, LLC

Originally posted on Dow.com Whirlpool Corporation, Dow, and Reynolds Consumer Products Collaborate to Manufacture and Donate Much-Needed Respirators Through WIN Health Labs, LLC ·       Companies create an alternative PPE solution to quickly address diminishing supply of N95 respirators and masks for healthcare workers ·       Dow and Whirlpool Corporation donating 1,000…

KPMG LLP Introduces Dynamic, Risk-Based, Policy and Technical Framework to Help Organizations Safely Reopen Workplaces

Originally published on home.kpmg.us. New approach centers on a policy framework assessing community and individual risk supported by process and technological solutions KPMG LLP has introduced a dynamic framework to help organizations implement approaches to bring employees back to workplaces. KPMG’s framework includes a technology-enabled and data-driven assessment of COVID-19-related…